Year: 2022

Castellum Announces That It Is One of The Winners Of The $900 million Air Force Architecture and Integration Directorate Multiple Award Indefinite Delivery/Indefinite Quantity Contract (AFLCMC/XA) (MAC IDIQ) Castellum, Inc. (NYSE: CTM) is pleased to announce that it is one of the winners of the Architecture and Integration Directorate Multiple Award Indefinite Delivery/Indefinite Quantity Contract (AFLCMC/XA) (MAC IDIQ) contract. Castellum’s award is through our subsidiary Specialty Systems, Inc. (SSI). This multiple award IDIQ prime contract has a ceiling of $900,000,000 and a 10-year period of performance and is with the Department of the Air Force, Air Force Materiel Command, Air Force Life Cycle Management Center, Architecture, and Integration Directorate – http://castellumus.com/POTOMAC, Md., Dec. 12, 2022 (GLOBE NEWSWIRE)...

Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2022 WEST LAFAYETTE, Ind., Dec. 12, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that it will delay the release and conference call related to its financial results for the fourth quarter and fiscal year ended September 30, 2022 (“FY 2022”) that was originally scheduled for after market close today. As previously disclosed, on November 16, 2022, the Company became aware that the U.S. Attorney’s Office for the Southern District of Florida (“USAO-SDFL”) had criminally charged employees of the...

WOODCLIFF LAKE, N.J., Dec. 12, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that it has reached a settlement agreement with Accord Healthcare, Inc. (“Accord”). Eagle had asserted its Orange Book-listed patents against Accord related to Accord’s new drug application (“NDA”) referencing BENDEKA®. The settlement agreement provides that Accord has the right to market its product beginning January 17, 2028, or earlier based on certain circumstances. The settlement agreement is confidential and subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice. The settlement with Accord follows Eagle’s previously announced settlement with Hospira, Inc. (“Hospira”) regarding two Orange Book-listed patents, which granted Hospira the right to market...

EXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it is offering to sell, subject to market and other conditions, shares of its common stock and shares of its Series A convertible preferred stock in two concurrent but separate underwritten public offerings. The offerings are being made by means of separate preliminary prospectus supplements and are not contingent upon each other. The offerings are subject to market and other conditions, and there can be no assurance as to whether or when the offerings may be completed or as to the actual size or terms of the offerings. RBC Capital Markets...

Explores The Trends Impacting Investment Opportunities In The Year Ahead NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”), today announced the release of Themes 2023. This annual handbook, assembled by the Company’s Research department, identifies themes in which Cowen’s collaborative approach and sector knowledge provide insights into the policies, trends and developments that are shaping industries. As in previous years, Themes 2023 builds off Cowen’s flagship Ahead Of The Curve® Series, the preeminent equity and policy research product for institutional investors and corporate decision makers. Themes 2023 can be accessed THEMES TO WATCH. Robert Fagin, Cowen’s Global Head of Research noted, “Cowen’s Themes publication leverages our analytical expertise and proprietary research and...

Signs Agreement for $39 Million Sale and Leaseback Transaction with Tenet Equity; Proceeds to be Used to Pay Down Portion of Outstanding Debt Enters into up to $37.5 Million Credit Agreement with Royal Bank of Canada SAN DIEGO and GAINESVILLE, Ga., Dec. 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced key progress in its multi-step strategy designed to recast the company’s capital structure and strengthen its balance sheet. The company is working toward the concurrent closing of separate transactions, which are intended to reduce and refinance its outstanding senior debt. First, Societal CDMO today announced...

Gofore Plc 12 December 2022 at 1.25 p.m. EETInside Information Inside information: Gofore Plc’s Business Review 1-30 November 2022: Net sales 17.2 million euros, year on year growth over 50% Inside information: In November 2022, Gofore’s net sales were 17.2 million euros (11.3 million euros in November 2021). The last 12 month (LTM) pro forma net sales were 153.3 million euros in November, including the numbers of eMundo GmbH that was consolidated into the Group on 1 November 2022. The Group employed 1,292 (846) people at the end of the month, including eMundo’s employees. CEO Mikael Nylund comments: ”November continued in the 2022 spirit of excellent growth for us. This time, a special mention from our sales activities goes to our cyber security services that have been in great demand all year. We have recently enhanced our capabilities...

COMPANY ANNOUNCEMENT no. 33 – 12 December 2022 DFDS will report and hold the Annual General Meeting (AGM) on the following dates in 2023: Deadline for submission of proposals to the AGM – 7 February Q4 and year-end report 2022 – 9 February         Annual report 2022 – 24 February AGM – 22 March Q1 report 2023 – 11 May Q2 report 2023 – 15 August Q3 report 2023 – 15 NovemberMonthly ferry volume updates will be released at around 10.00am CET on the following dates in 2023: 12 January9   February13 March12 April11 May13 June12 July15 August12 September12 October15 November12 DecemberContact Søren Brøndholt Nielsen, IR +45 33 42 33 59About DFDS DFDS provides ferry and transport services in and around Europe, generating annual revenues of around DKK 25bn. To over 10,000 freight customers,...